Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, (Alternext – FR0011648971 – ALQGC), has announced today a capital increase by additional private placements of 240 K€ at the same price per share as the private placement of 3.4 M€ made on April 9th.
[button link=”http://www.quantum-genomics.com/uploads/file/QGC_PR_20140425_UK.PDF” target=”_blank” title=”Download the pdf” size=”small” color=”red”]
